We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

April 7, 2003

GARBER, et al v. PHARMACIA CORP, et al

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. October 9, 2012

    Pfizer Inks $164M Settlement In Celebrex Securities Suit

    Pfizer Inc. agreed Friday to pay $164 million to settle a certified securities fraud class action in New Jersey federal court alleging it made materially false statements about a clinical study of blockbuster anti-inflammatory drug Celebrex, ending a much-publicized case that was set for trial later this month.


Parties

To view the parties, register now.